Tag: AHA 2016
AHA 2016: Mortality rate with FFR-guided treatment of multivessel disease is unexpectedly high
The results of the FU...
AHA 2016: Strong positive one-year data for Corvia Medical’s InterAtrial shunt device
Corvia Medical has announ...
AHA 2016: Incomplete revascularisation after PCI increases risk of adverse events after surgery
Ehrin J Armstrong (Se...
AHA 2016: Two thirds of patients experience plaque regression with the PCSK9 inhibitor evolocumab
Amgen has announced t...
